Effect of Prereperfusion Ephedrine on Postreperfusion Syndrome and Graft Function in Living Donor Liver Transplantation.
暂无分享,去创建一个
J. Ko | M. Gwak | G. Kim | S. J. Choi | I. Chung | S. Lee | H. S. Jee | S. Han | G. Kim | S. J. Choi | S.-K. Lee
[1] Hyung‐Chul Lee,et al. Epinephrine and phenylephrine pretreatments for preventing postreperfusion syndrome during adult liver transplantation , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[2] H. Kim,et al. Incidence and predictors of post‐reperfusion syndrome in living donor liver transplantation , 2012, Clinical transplantation.
[3] H. Ryu,et al. Nafamostat Mesilate Attenuates Postreperfusion Syndrome during Liver Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] M. Ramsay,et al. Postreperfusion syndrome during liver transplantation for cirrhosis: Outcome and predictors , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[5] M. Gwak,et al. Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation. , 2008, Transplantation proceedings.
[6] A. Marcos,et al. The impact of postreperfusion syndrome on short‐term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[7] K. Jauch,et al. Effect of graft steatosis on liver function and organ survival after liver transplantation. , 2008, American journal of surgery.
[8] S. Homer-Vanniasinkam,et al. Reperfusion Syndrome: Cellular Mechanisms of Microvascular Dysfunction and Potential Therapeutic Strategies , 2007, Vascular and endovascular surgery.
[9] J. Figueras,et al. Hemodynamic profile and tissular oxygenation in orthotopic liver transplantation: Influence of hepatic artery or portal vein revascularization of the graft , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[10] Y. Tokat,et al. Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. , 2003, Transplantation proceedings.
[11] J. Findlay,et al. Aprotinin reduces vasoactive medication use during adult liver transplantation. , 2003, Journal of clinical anesthesia.
[12] M. Gwak,et al. The Comparison of Coagulation Status in the Cadaveric Donor and Living-Related Liver Transplantation , 2002 .
[13] M. Bellamy,et al. The Effect of Methylene Blue on the Hemodynamic Changes During Ischemia Reperfusion Injury in Orthotopic Liver Transplantation , 2002, Anesthesia and analgesia.
[14] A. Nanashima,et al. Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center. , 2001, Journal of hepato-biliary-pancreatic surgery.
[15] M. Bernardi,et al. INCREASED GENERATION OF REACTIVE OXYGEN SPECIES IN ISOLATED RAT FATTY LIVER DURING POSTISCHEMIC REOXYGENATION1 , 2001, Transplantation.
[16] A. Sheil,et al. Postreperfusion syndrome in orthotopic liver transplantation. , 2000, Transplantation proceedings.
[17] H. Putter,et al. Reduced Need for Vasopressors in Patients Receiving Aprotinin during Orthotopic Liver Transplantation , 2000, Anesthesiology.
[18] P. Parrilla,et al. Influence of surgical technique on postreperfusion syndrome during liver transplantation. , 1999, Transplantation proceedings.
[19] S. Belle,et al. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. , 1998, Transplantation.
[20] D. Kitzman,et al. Treatment of Hypotension after Hyperbaric Tetracaine Spinal Anesthesia: A Randomized, Double‐blind, Cross‐over Comparison of Phenylephrine and Epinephrine , 1997, Anesthesiology.
[21] D. Kitzman,et al. treatment of Hypotension after Hyperbaric Tetracaine Spinal Anesthesia : a Randomized, Double-blind, Cross-over Comparison of Phenylephrine and Epinephrine , 1997 .
[22] E. Munson,et al. Comparison of arrhythmic doses of adrenaline, metaraminol, ephedrine and phenylephrine during isoflurane and halothant anaesthesia in dogs. , 1974, British journal of anaesthesia.
[23] H. Bonatti. Use of Severely Steatotic Grafts in Liver Transplantation: A Matched Case-Control Study , 2008 .
[24] M. Columb,et al. Equivalent dose of ephedrine and phenylephrine in the prevention of post-spinal hypotension in Caesarean section. , 2006, British journal of anaesthesia.